Cannabis Technologies (C.CAN) knocks out more cannabinoid biotech IP

Source: Chris Parry, Stockhouse.com Aug 19 2014 If the medical marijuana sector exists as a single entity, biotech performer Cannabis Technologies (CSE:C.CAN, Stock Forum) is one of its poster children, and news out today will only serve to reinforce that perception. The company announced Monday that it has developed a second therapy using cannabinoid and…

The post Cannabis Technologies (C.CAN) knocks out more cannabinoid biotech IP appeared first on Marijuana Index.